Glovadalen, a novel D1 receptor positive allosteric modulator, is linked to improve OFF time in patients with Parkinson’s ...
Disease modifying mechanism of action: short treatment course results in significant and durable clinical response in psoriasis patients si-544 is the first highly potent and selective Kv1.3 blocker ...
Celldex Therapeutics, Inc. (NASDAQ:CLDX) is one of the best small cap stocks with the highest upside. Barclays initiated ...
Grisso, a microbial science company, today announced the launch of its clinically-validated, precision probiotic product line, entering a market increasingly defined by consumer skepticism and demand ...
Confirmation by several European agencies and the U.S. FDA of the relevance of the continuous abstinence validation criteria which showed statistical significance (p=0.02) in the Phase 2 CESTO II ...
Panelists discuss how maintaining patients on effective single therapies for Crohn’s disease is preferable to switching ...
Discover how kiwifruit’s unique blend of fiber, vitamin C, and actinidin supports gut function, strengthens immunity, and ...
Stop breastfeeding!” Serena Williams’s coach barks at her before telling her she is “too heavy” and watching her burst into ...
Race identifies primary mechanism of action for (E,E)-bisantrene (RCDS1), the active compound underpinning its lead candidate RC220 drug Targeting G4-DNA and RNA structures by RCDS1 reduces the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback